Bartter Syndrome
From Anvita Health Wiki
Contents |
More Specific Terms
- Bartter syndrome type 1 (SLC12A1 linked)
- Bartter syndrome type 2 (hyperprostanglandin E syndrome 2, KCNJ1 linked)
- Bartter syndrome type 3 (classic Bartter syndrome)
- Bartter syndrome type 4 (infantile Bartter syndrome with sensorineural deafness)
Introduction
- Primary juxtaglomerular cell hyperplasia with secondary hyperaldosteronism
- Primary juxtaglomerular cell hyperplasia with secondary hyperaldosteronism
- (Also see hyperaldosteronism.)
Etiology
- genetic defect in chloride reabsorption in the thick ascending loop of Henle
Epidemiology
- occurs in children
Pathology
- defect in chloride reabsorption in the thick ascending loop of Henle
- defect in sodium reabsorption
- pronounced salt wasting
- secondary hyperaldosteronism
- hypokalemic metabolic alkalosis
- varying degrees of hypercalciuria
- overproduction of prostaglandins
- hyperplasia of juxtaglomerular & medullary interstitial cells
Genetics
Clinical-manifestations
- normal blood pressure
- no edema
- polyuria
- nocturia
- growth is generally retarded
Laboratory
- arterial blood gas: metabolic alkalosis
- aldosterone markedly increased
- renin mildly to moderately increased
- hypomagnesemia
- hypokalemia
- urinalysis: urine chloride > 20 meq/L
- biopsy: juxtaglomerular hyperplasia
Management
- prostaglandin inhibitors are temporarily effective
- potassium supplementation
- spironolactone ( Aldactone)
- ACE inhibitor
More General Terms
Additional Terms
Internet Database
OMIM: 241200
OMIM: 600359
OMIM: 600839
References
- Harrison's Principles of Internal Medicine, 14th ed. Fauci et al (eds), McGraw-Hill Inc. NY, 1998, pg 2049
- Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 622
- Harrison's Principles of Internal Medicine, 13th ed. Isselbacher et al (eds), McGraw-Hill Inc. NY, 1994, pg 1324
